PPMI at AAN 2015

PPMI is headed to the American Academy of Neurology (AAN) 2015 Annual Meeting.  The meeting takes place in Washington D.C. from April 18 through April 25.   Top players in neurology will come together to learn about  the latest in research, showcased through presentations and posters.  PPMI data will be featured throughout the conference at the following sessions:

Tuesday, April 21

P2: Poster Session II: Movement Disorders: Parkinson’s Disease Genetics and Biomarkers

Using Non-Motor Features to Define Clinical and Biomarker Patterns of Early Drug-Naïve Parkinson Disease – Presenter: Samay Jain

Objective Measurement of Upper Extremity Motor Function in the Parkinson?s Progression Markers Initiative – Presenter: Lama Chahine

P3: Poster Session III: Movement Disorders Poster Discussion Session

Identifying Parkinson Disease with Non-Motor Features and CSF Biomarkers: A Case-Control Study – Presenter: Samay Jain

Non-Motor Symptoms in Early Drug-Naive Parkinson Disease – Presenter: Rui Liu

P6: Poster Session VI: Movement Disorders: Parkinson’s Disease

Plasma ApoA1 Associates with Age at Onset and Motor Severity in Early Parkinson Disease Patients – Presenter: Christine Swanson

Wednesday, April 22

P5: Poster Session V: Aging, Dementia, Cognitive, and Behavioral Neurology: Amyloid and Biomarkers

Presence of Cerebral Amyloid Modulates Phenotype and Pattern of Neurodegeneration in early Parkinson?s Disease – Presenter: Corey McMillan

S32: Platform Session: Movement Disorders: Tremor, Ataxia, and More Platform Blitz

CSF A?1-42 predicts cognitive impairment in de novo PD patients – Presenter: Mark Terrelonge

Thursday, April 23

S40: Platform Session: Movement Disorders: Functional Imaging in Parkinson’s Disease

Assessment of Parkinson disease progression using 123- I I-Ioflupane SPECT: Update from the Parkinson Progression Marker Initiative Trial – Presenter: John Seibyl

Clinical Correlates of Raphe Serotonergic System Dysfunction in Early Parkinson?s Disease – Presenter: Zahi Qamhawi

INS Poster Session: The Promise of Novel Biomarker Approaches in Advancing Treatment Poster Presentations

Assessment of Parkinson disease progression using 123- I I-Ioflupane SPECT: Update from the Parkinson Progression Marker Initiative Trial – Presenter: John Seibyl

For the first time, The Michael J. Fox Foundation (MJFF) is also exhibiting at the AAN meeting.  Visit booth #931 to discuss PPMI with MJFF staff members.

For more information about the meeting, including a full program, please visit AAN 2015.